Effects of oestradiol for luteal phase support in fresh embryo transfer cycles: A retrospective cohort study. (29th May 2018)
- Record Type:
- Journal Article
- Title:
- Effects of oestradiol for luteal phase support in fresh embryo transfer cycles: A retrospective cohort study. (29th May 2018)
- Main Title:
- Effects of oestradiol for luteal phase support in fresh embryo transfer cycles: A retrospective cohort study
- Authors:
- Zhao, Wei
Liu, Yifeng
Xu, Peng
Wu, Yiqing
Chen, Kai
Guo, Xiaoyan
Zhang, Fan
Huang, Yun
Zhu, Linlin
Zhang, Runjv
Zhang, Dan - Abstract:
- Summary: Objective: Any benefit of oestradiol supplementation with progesterone for luteal support after fresh embryo transfer in in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) cycles remains controversial. In this study, we further addressed this question in cycles using gonadotropin‐releasing hormone (GnRH) agonist for ovarian stimulation. Design: A retrospective cohort study in a tertiary teaching and research hospital. Patient(s): A total of 1602 patients were given oestradiol valerate (E) in addition to progesterone (P) as luteal support. One thousand six hundred and two patients receiving progesterone alone were selected as the control group. Main outcome measure(s): Live birth rate. Secondary measures included clinical pregnancy rate, miscarriage rate and premature birth rate. Result(s): Clinical pregnancy and live birth rates were similar for the P alone vs the P+E group. In cycles with oestradiol (E2) levels less than 5000 pmol/L on the day of hCG trigger, E supplementation resulted in a significantly higher live birth rate (23.44% vs 32.92%, OR = 1.60 [95% CI 1.05 to 2.46]). In cycles with oestradiol levels 5000 to 10 000 pmol/L on the day of hCG trigger, E supplementation did not increase the live birth rate (34.43% vs 35.42%, OR = 0.90 [95% CI 0.80 to 1.01]). In cycles with oestradiol levels over 10 000 pmol/L on the day of hCG trigger, the live birth rate was significantly lower (36.83% vs 31.37%, OR = 0.78 [95% CI 0.62 to 0.99]) and theSummary: Objective: Any benefit of oestradiol supplementation with progesterone for luteal support after fresh embryo transfer in in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) cycles remains controversial. In this study, we further addressed this question in cycles using gonadotropin‐releasing hormone (GnRH) agonist for ovarian stimulation. Design: A retrospective cohort study in a tertiary teaching and research hospital. Patient(s): A total of 1602 patients were given oestradiol valerate (E) in addition to progesterone (P) as luteal support. One thousand six hundred and two patients receiving progesterone alone were selected as the control group. Main outcome measure(s): Live birth rate. Secondary measures included clinical pregnancy rate, miscarriage rate and premature birth rate. Result(s): Clinical pregnancy and live birth rates were similar for the P alone vs the P+E group. In cycles with oestradiol (E2) levels less than 5000 pmol/L on the day of hCG trigger, E supplementation resulted in a significantly higher live birth rate (23.44% vs 32.92%, OR = 1.60 [95% CI 1.05 to 2.46]). In cycles with oestradiol levels 5000 to 10 000 pmol/L on the day of hCG trigger, E supplementation did not increase the live birth rate (34.43% vs 35.42%, OR = 0.90 [95% CI 0.80 to 1.01]). In cycles with oestradiol levels over 10 000 pmol/L on the day of hCG trigger, the live birth rate was significantly lower (36.83% vs 31.37%, OR = 0.78 [95% CI 0.62 to 0.99]) and the premature birth rate was significantly higher (19.66% vs 28.73%, OR = 1.65 [95% CI 1.05 to 2.59]) in the E supplementation group. Conclusion(s): Any benefit of oestradiol supplementation for luteal phase support appears to correlate with the serum oestradiol level on the day of hCG trigger. Oestradiol supplementation is beneficial for improving live birth rate in cycles with oestradiol levels less than 5000 pmol/L, but is not recommended in cycles with oestradiol levels over 10 000 pmol/L. … (more)
- Is Part Of:
- Clinical endocrinology. Volume 89:Number 2(2018)
- Journal:
- Clinical endocrinology
- Issue:
- Volume 89:Number 2(2018)
- Issue Display:
- Volume 89, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 89
- Issue:
- 2
- Issue Sort Value:
- 2018-0089-0002-0000
- Page Start:
- 194
- Page End:
- 201
- Publication Date:
- 2018-05-29
- Subjects:
- gonadotropin‐releasing hormone agonist -- live birth -- luteal phase support -- oestradiol -- premature birth
Endocrinology -- Periodicals
616.4005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2265 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cen.13740 ↗
- Languages:
- English
- ISSNs:
- 0300-0664
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.278000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9352.xml